Chrysophanic acid, or chrysophanol, is an anthraquinone found in Rheum palmatum, which was used in the preparation of oriental medicine in ancient China. The hippocampus plays a major role in controlling the activities of the short- and long-term memory. It is one of the major regions affected by excessive cell death in Alzheimer's disease. Therefore, neuronal cell-death modulation in the hippocampus is important for maintaining neuronal function. We investigated chrysophanol's effects on glutamate-induced hippocampal neuronal cell death. Chrysophanol reduced glutamate-induced cell death via suppression of proapoptotic factors and reactive oxygen species generation. Furthermore, it downregulated glutamate-induced mitochondrial fission by inhibiting dynamin-related protein 1 (Drp1) dephosphorylation. Thus, chrysophanol suppressed hippocampal neuronal cell death via inhibition of Drp1-dependent mitochondrial fission, and can be used as a therapeutic agent for treating neuronal cell death-mediated neurodegenerative diseases.

1.
Yang X, Yang L, Wang S, Yu D, Ni H: Synergistic interaction of physcion and chrysophanol on plant powdery mildew. Pest Manag Sci 2007;63:511-515.
2.
Li Y, Tian S, Yang X, Wang X, Guo Y, Ni H: Transcriptomic analysis reveals distinct resistant response by physcion and chrysophanol against cucumber powdery mildew. PeerJ 2016;4:e1991.
3.
Zhang J, Yan C, Wang S, Hou Y, Xue G, Zhang L: Chrysophanol attenuates lead exposure-induced injury to hippocampal neurons in neonatal mice. Neural Regen Res 2014;9:924-930.
4.
Reiman EM: Alzheimer's disease: attack on amyloid-β protein. Nature 2016;537:36-37.
5.
Grayson M: Parkinson's disease. Nature 2016;538:S1.
6.
Tsuji S: Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet 2010;19:R65-R70.
7.
Soto C, Estrada LD: Protein misfolding and neurodegeneration. Arch Neurol 2008;65:184-189.
8.
Takalo M, Salminen A, Soininen H, Hiltunen M, Haapasalo A: Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis 2013;2:1-14.
9.
Johri A, Beal MF: Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 2012;342:619-630.
10.
da Rocha MD, Viegas FP, Campos HC, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr: The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease. CNS Neurol Disord Drug Targets 2011;10:251-270.
11.
Ni CH, Yu CS, Lu HF, Yang JS, Huang HY, Chen PY, Wu SH, Ip SW, Chiang SY, Lin JG, Chung JG: Chrysophanol-induced cell death (necrosis) in human lung cancer A549 cells is mediated through increasing reactive oxygen species and decreasing the level of mitochondrial membrane potential. Environ Toxicol 2014;29:740-749.
12.
Squire B: Chrysophanic acid as a remedy in skin-disease. Br Med J 1877;1:199.
13.
Zhang N, Zhang X, Liu X, Wang H, Xue J, Yu J, Kang N, Wang X: Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice. Mediators Inflamm 2014;2014:370530.
14.
Bird CM, Burgess N: The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 2008;9:182-194.
15.
Moodley KK, Chan D: The hippocampus in neurodegenerative disease. Front Neurol Neurosci 2014;34:95-108.
16.
Mishra P, Chan DC: Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol 2014;15:634-646.
17.
Dorn GW 2nd, Vega RB, Kelly DP: Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev 2015;29:1981-1991.
18.
Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X: Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 2010;1802:135-142.
19.
Suen DF, Norris KL, Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev 2008;22:1577-1590.
20.
Willems PH, Rossignol R, Dieteren CE, Murphy MP, Koopman WJ: Redox homeostasis and mitochondrial dynamics. Cell Metab 2015;22:207-218.
21.
Uttara B, Singh AV, Zamboni P, Mahajan RT: Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65-74.
22.
Zhang C, Lee S, Peng Y, Bunker E, Shen C, Giaime E, Shen J, Zhou Z, Liu X: A chemical genetic approach to probe the function of PINK1 in regulating mitochondrial dynamics. Cell Res 2015;25:394-397.
23.
Kim TS, Choi HS, Ryu BY, Gang GT, Kim SU, Koo DB, Kim JM, Han JH, Park CK, Her S, Lee DS: Real-time in vivo bioluminescence imaging of lentiviral vector-mediated gene transfer in mouse testis. Theriogenology 2010;73:129-138.
24.
Siesjo BK, Zhao Q, Pahlmark K, Siesjo P, Katsura K, Folbergrova J: Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg 1995;59:1316-1320.
25.
Zhang Y, Bhavnani BR: Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci 2006;7:49.
26.
Schelman WR, Andres RD, Sipe KJ, Kang E, Weyhenmeyer JA: Glutamate mediates cell death and increases the Bax to Bcl-2 ratio in a differentiated neuronal cell line. Brain Res Mol Brain Res 2004;128:160-169.
27.
Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S: Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett 2001;497:1-5.
28.
Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, Muller WE: Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 2003;66:1627-1634.
29.
Burte F, Carelli V, Chinnery PF, Yu-Wai-Man P: Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol 2015;11:11-24.
30.
Lu CC, Yang JS, Huang AC, Hsia TC, Chou ST, Kuo CL, Lu HF, Lee TH, Wood WG, Chung JG: Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res 2010;54:967-976.
31.
Herzog ED: Neurons and networks in daily rhythms. Nat Rev Neurosci 2007;8:790-802.
32.
Mattson MP: Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000;1:120-129.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.